Specific biomarker predicts which HER2-negative breast cancer patients respond to tar

[News]

A multicenter team led by Case Western Reserve has demonstrated that brief exposure to a targeted therapy can tell doctors which HER2-negative patients will respond — and which should switch to another kind of treatment.

More... (http://www.news-medical.net/news/20150918/Specific-biomarker-predicts-which-HER2-negative-breast-cancer-patients-respond-to-targeted-therapy.aspx)